| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 743853 | Null | 0.0273093708703115 | 0.14157764 |
| NSC 750421 | Null | 0.0273093708703115 | -0.31221842 |
| NSC 750743 | (E)-3-(6-(thiophen-2-yl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | 0.0273093708703115 | 0.12464898 |
| NSC 754240 | 2,9-dimethoxy-6-(2-(piperidin-1-yl)ethoxy)-11H-indeno[1,2-c]quinolin-11-one | 0.0273093708703115 | -0.24583893 |
| NSC 762149 | N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)acetamide | 0.0273093708703115 | 0.3275168 |
| NSC 92915 | ANTINEOPLASTIC-92915 | 0.0273093708703115 | 0.096656161 |
| NSC 675278 | 5-Hydroxy-7-amino(1,2,3)thiadiazole[5,4-d]pyrimidine | 0.0282295482823984 | 0.20764509 |
| NSC 678473 | Null | 0.0282295482823984 | -0.044498317 |
| NSC 683086 | Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- | 0.0282295482823984 | 0.034801209 |
| NSC 689531 | Hydrazinecarbothioamide, 2-[(2-pyridinyl)phenylmethylene]-N-[2-(2-pyridinyl)ethyl]- | 0.0282295482823984 | -0.20487353 |